Cargando…

Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study.

Twenty-three patients with pleural mesothelioma stage I-IIA were entered in a study of continuous daily intrapleural infusion of interleukin 2 (IL-2) for 14 days, repeated every 4 weeks. IL-2 was administered according to a groupwise dose escalation schedule (group A, 3 x 10(4); group B, 3 x 10(5);...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goey, S. H., Eggermont, A. M., Punt, C. J., Slingerland, R., Gratama, J. W., Oosterom, R., Oskam, R., Bolhuis, R. L., Stoter, G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033917/ https://www.ncbi.nlm.nih.gov/pubmed/7577483

Ejemplares similares

Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma.
por: Kruit, W. H., et al.
Publicado: (1996)

Immune responses following intrapleural administration of oncolytic SEPREHVIR in patients with malignant pleural mesothelioma
por: Learmonth, Kirsty, et al.
Publicado: (2015)

Hyperbilirubinaemia in patients treated with recombinant human interleukin-2 (rIL-2)
por: Punt, C. J., et al.
Publicado: (1990)

Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancer.
por: Goey, S. H., et al.
Publicado: (1996)

Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma
por: Chintala, Navin K., et al.
Publicado: (2023)

Intrapleural silicone granuloma mimicking pleural malignancy
por: Vo, Kiet, et al.
Publicado: (2021)

Intrapleural Tenecteplase for Complicated Parapneumonic Pleural Effusion
por: Kadhem, Husain, et al.
Publicado: (2021)

Final report of a phase II study of interleukin 2 and interferon alpha in patients with metastatic melanoma.
por: Kruit, W. H., et al.
Publicado: (1995)

An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocol
por: Tada, Yuji, et al.
Publicado: (2016)

Intrapleural Adenoviral-mediated Endothelial Cell Protein C Receptor Gene Transfer Suppresses the Progression of Malignant Pleural Mesothelioma in a Mouse Model
por: Keshava, Shiva, et al.
Publicado: (2016)

Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
por: Takeuchi, Eiji, et al.
Publicado: (2020)

Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma
por: van Haarst, J M W, et al.
Publicado: (2002)

Short-course modified regimen intrapleural alteplase and pulmozyme (DNase) in pleural infection
por: Faisal, M., et al.
Publicado: (2020)

Medical management of pleural infection: Why not saline intrapleural lavage?
por: Mismetti, Valentine, et al.
Publicado: (2022)

Rethinking the Doses of Tissue Plasminogen Activator and Deoxyribonuclease Administrated Concurrently for Intrapleural Therapy for Complicated Pleural Effusion and Empyema
por: Innabi, Ayoub, et al.
Publicado: (2018)

Massive hemothorax following administration of intrapleural streptokinase
por: Chai, Feng Yih, et al.
Publicado: (2011)

Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report
por: Klanova, Magdalena, et al.
Publicado: (2012)

Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusion
por: Moon, Youngkyu, et al.
Publicado: (2015)

The Intrapleural Bridge Connection is One of the Reasons for Unknown Localized Pleural Adhesion
por: Gu, Qihua, et al.
Publicado: (2021)

Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial.
por: Stouthard, J. M., et al.
Publicado: (1996)

Intrapleural interleukin-2–expressing oncolytic virotherapy enhances acute antitumor effects and T-cell receptor diversity in malignant pleural disease
por: Ekeke, Chigozirim N., et al.
Publicado: (2022)

Extrathoracic Metastases in Pleural Mesothelioma
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis
por: Wang, Cheng-Qiong, et al.
Publicado: (2021)

Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma
por: Belderbos, Robert A., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Comparison of intrapleural use of urokinase and tissue plasminogen activator/DNAse in pleural infection
por: Bédat, Benoît, et al.
Publicado: (2019)

Can intrapleural alteplase treatment be an alternative to videothoracoscopic deloculation and decortication in pleural empyema?
por: Kermenli, Tayfun, et al.
Publicado: (2021)

Ambulatory Intrapleural Fibrinolytic Therapy in Highly Viscous Recurrent Malignant Pleural Effusion
por: Foo, Chuan Tai, et al.
Publicado: (2021)

Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections
por: McClune, Jason R., et al.
Publicado: (2016)

Effect of Intrapleural Fibrinolytic Therapy vs Surgery for Complicated Pleural Infections: A Randomized Clinical Trial
por: Wilshire, Candice L., et al.
Publicado: (2023)

Intrapleural Tissue Plasminogen Activator and Dornase Alfa Administration for a Multiloculated Recurrent Malignant Pleural Effusion: A Case Report
por: Nikoomanesh, Kia, et al.
Publicado: (2022)

Optimization of a Luciferase-Expressing Non-Invasive Intrapleural Model of Malignant Mesothelioma in Immunocompetent Mice
por: Digifico, Elisabeth, et al.
Publicado: (2020)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma.
por: Nakano, T., et al.
Publicado: (1998)

Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study
por: Pagano, Maria, et al.
Publicado: (2020)

Intrapleural Corticosteroid Injection in Eosinophilic Pleural Effusion Associated with Undifferentiated Connective Tissue Disease
por: Kim, Eunjung, et al.
Publicado: (2013)

Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion
por: Acencio, Milena Marques Pagliarelli, et al.
Publicado: (2017)

An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection
por: Lau, Estee P.M., et al.
Publicado: (2022)

Asbestos Burden Predicts Survival in Pleural Mesothelioma
por: Christensen, Brock C., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8pstgnikjvb4slkpknd2qcvqvl